A detailed history of Cetera Investment Advisers transactions in Organon & Co. stock. As of the latest transaction made, Cetera Investment Advisers holds 46,718 shares of OGN stock, worth $713,851. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,718
Previous 58,599 20.28%
Holding current value
$713,851
Previous $1.21 Million 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $221,580 - $273,619
-11,881 Reduced 20.28%
46,718 $893,000
Q2 2024

Aug 22, 2024

BUY
$17.45 - $21.96 $24,046 - $30,260
1,378 Added 2.41%
58,599 $1.21 Million
Q1 2024

May 24, 2024

BUY
$13.78 - $18.8 $788,505 - $1.08 Million
57,221 New
57,221 $1.08 Million
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $68,744 - $108,734
6,278 Added 50.78%
18,642 $268,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $205,118 - $293,892
12,364 New
12,364 $214,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $28,681 - $42,955
-1,339 Reduced 12.11%
9,722 $228,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $257,831 - $316,455
11,061 New
11,061 $309,000
Q2 2022

Aug 11, 2022

SELL
$31.66 - $38.9 $35,870 - $44,073
-1,133 Reduced 12.65%
7,825 $264,000
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $10,657 - $13,776
-350 Reduced 3.76%
8,958 $313,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $27,609 - $35,756
-963 Reduced 9.38%
9,308 $283,000
Q3 2021

Nov 16, 2021

SELL
$28.63 - $35.64 $60,724 - $75,592
-2,121 Reduced 17.12%
10,271 $337,000
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $352,552 - $470,896
12,392 New
12,392 $375,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.